A Copper-Based Drug Clears Buildup of Alzheimer's Proteins in Mice
Reported byScienceAlert ↗·Sourced by Goodlede
A copper-based compound successfully cleared amyloid and tau protein buildup in mice, offering a new therapeutic pathway for Alzheimer's disease treatment.
Mouse studies do not guarantee human efficacy; drug development from preclinical to clinical trials typically spans years.
Goodlede runs a two-pass source check on every story: one pass finds it, a second skeptical pass re-verifies the claim and writes what it doesn’t prove. This is a source check, not an independent fact-check — confirm anything important at the link above.
Read the full story at ScienceAlert
Read original story ↗↻ Refreshed daily
More good news, verified daily.
Goodlede covers positive developments across science, nature, rights, and human achievement — verified before they appear. No hype, no roundups, no PR wires.
© 2026 Wag Media, LLC
More from Goodlede
Environment
Study offers first map of Amazon's climate-resilient upslope corridors
Mongabay · Verified
Health
'Groundbreaking' Potential Lupus Cure Sends Patients into Remission, Allowing Dreams to Be Fulfilled
Good News Network · Verified
Science
NASA's Webb Finds Clues to Ancient, Distant Origin of Comet 3I/ATLAS
NASA · Verified